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Abstract
When simultaneously testing multiple hypotheses, the usual approach in the context of confirma-
tory clinical trials is to control the familywise error rate (FWER), which bounds the probability of
making at least one false rejection. In many trial settings, these hypotheses will additionally have
a hierarchical structure that reflects the relative importance and links between different clinical
objectives. The graphical approach of Bretz et al. (2009) is a flexible and easily communicable
way of controlling the FWER while respecting complex trial objectives and multiple structured
hypotheses. However, the FWER can be a very stringent criteria that leads to procedures with a
low power, and may not be appropriate in exploratory trial settings. This motivates controlling
generalised error rates, particularly when the number of hypotheses tested is no longer very small.
We consider the generalised familywise error rate (k-FWER), which is the probability of making k
or more false rejections, as well as the tail probability of the false discovery proportion (FDP),
which is the probability that the proportion of false rejections is greater than some threshold. We
also consider asymptotic control of the false discovery rate (FDR), which is the expectation of the
FDP. In this paper, we show how to control these generalised error rates when using the graphical
approach and its extensions. We demonstrate the utility of the resulting graphical procedures on
three clinical trial case studies.
Keywords: False discovery proportion; generalised familywise error rate; hypothesis testing; multiple
endpoints; multiple comparison procedures.
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1 Introduction
In modern clinical trials, it is increasingly common to test multiple hypotheses simultaneously. This
multiplicity is driven by evaluating multiple therapies in parallel, the identification of multiple sub-
groups and the measurement of multiple endpoints. Given that these multiple hypotheses are assessed
simultaneously, there is a strong emphasis on controlling the total number or proportion of false posi-
tives (i.e. type I errors) in some way. Indeed, for confirmatory clinical trials, regulatory guidelines state
that the familywise error rate (FWER) should be strongly controlled (Food and Drug Administration
2017, European Medicines Agency 2017). This ensures that the maximum probability of making at
least one type I error is below some pre-specified level (under any configuration of the parameters
being tested).
The increase in multiplicity in clinical trials also tends to go hand-in-hand with an increase in
the complexity of the objectives and structure of the hypotheses tested. A key setting where this
occurs is when measuring multiple endpoints to answer distinct (but related) clinical questions. The
corresponding hypotheses often fit naturally within a hierarchical structure that reflects the relevant
importance and links between the clinical questions that the trial aims to answer. For example, in a
trial with both a primary and secondary hypothesis, the trialist may only wish to test the secondary
hypothesis if the primary hypothesis is first rejected. More complex hierarchical structures can be
formed as the number of hypotheses increases.
Many methods have been developed for FWER control that respect complex trial objectives and
multiple structured hypotheses. A highly flexible framework for doing so is the graphical approach to
hypothesis testing, as proposed independently by Bretz et al. (2009) and Burman et al. (2009). In the
framework of Bretz et al. (2009), vertices represent the null hypotheses and weights represent the local
significance levels, which are propagated through weighted, directed edges. The resulting multiple test-
ing procedure can be tailored to structured families of hypotheses with arbitrary dependence between
the hypotheses, and allows the visualisation of complex decision strategies in an easily communicable
way. Many well-known procedures for FWER control are special cases of the graphical approach, such
as the fixed sequence (or hierarchical) test (Maurer et al. 1995), the Holm procedure (Holm 1979), the
Hochberg procedure (Xi & Bretz 2019) and several gatekeeping procedures (Dmitrienko et al. 2003,
2008, Li et al. 2019).
However, controlling the FWER is a very stringent criterion, especially as the number of hypotheses
increases. By controlling the probability of even a single type I error, the power of FWER-controlling
procedures can be very low, with little chance of any of the individual hypotheses being rejected. While
strong FWER control is appropriate in confirmatory contexts, in exploratory trial settings such strict
criterion may not be necessary. Indeed, as reflected in the FDA (2017) guidance on multiple endpoints
in clinical trials (Food and Drug Administration 2017), exploratory analyses can be included in a trial
to explore and generate new hypotheses. Since such exploratory hypotheses will often be followed up
with confirmatory testing, strict FWER control at the exploratory stage is no longer necessary.
Westfall & Bretz (2018) expand on this argument, by categorising the hypothesis tests in a typical
clinical trial into families of “efficacy”, “safety” and “exploratory” tests. For the efficacy family, the
primary endpoints and main secondary endpoints are the basis of regulatory approval and labelling,
and hence require strong FWER control. However, there may also be “lesser interest tests” (for ex-
ample, multiple time point analyses), where FWER controlling methods are not needed. Nonetheless,
the authors note that some form of multiplicity adjustment would strengthen the claims made for
this set of tests. For the safety family, serious and known treatment-related adverse events (AEs) do
not require multiplicity adjustment (since type II errors are of much greater concern). However, for
all other AEs, the authors state that there is a clear need to recognise the multiplicity problem, and
note that the use of the FDR may be more appropriate here. Finally, for the family of exploratory
tests (which may include both safety and efficacy tests), the authors state that “standard multiplicity
adjustment here seems unreasonable, as power will be very low”, and again recommend the use of
FDR controlling methods.
All this demonstrates that outside of the context of testing the primary and main secondary end-
points for regulatory approval and labelling, strong FWER control may not be needed, even in con-
firmatory trials. Less stringent error rates can then be used, where more than one false rejections are
acceptable in order to increase the power of the trial. One approach is to control the generalised FWER,
or k-FWER. The k-FWER is the probability of making at least k false rejections, where k ≥ 1. Clearly
the FWER is a special case of the k-FWER when k = 1. A number of methods controlling the k-FWER
have been proposed, including step-up procedures (Lehmann & Romano 2005, Romano & Shaikh
2006b, Sarkar 2007, Wang & Xu 2012) and permutation-based procedures (Romano & Wolf 2007,
Romano et al. 2008, Romano & Wolf 2010). Another approach is to accept a certain proportion of
false rejections, i.e. to control the false discovery proportion (FDP). The FDP is closely related to the
well-known false discovery rate (FDR) (Benjamini & Hochberg 1995), which is now a common error
rate to control in experiments with a large number of hypotheses, such as genomic studies. The FDR
is the expected value of the FDP, i.e. the FDR is the expected proportion of errors among the rejected
hypotheses. Although controlling the FDR controls the expectation of the FDP, in practical applica-
tions the actual FDP might be far from its expectation (Owen 2005). In the context of clinical trials
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with a relatively small number (< 100) of hypotheses, this motivates control of the tail probability of
the FDP and hence guaranteeing control over the probability of having a high proportion of false dis-
coveries. Some methods for controlling the FDP have previously been proposed (Lehmann & Romano
2005, Romano et al. 2008, Romano & Shaikh 2006a).
In general, the various procedures proposed in the literature for generalised error rate control are
not suitable for structured hypothesis testing problems encountered in the context of clinical trials, as
they do not respect the underlying hierarchical structure of the testing strategy. In order to do so, in
this paper we show how to control both the k-FWER and FDP (as well as asymptotic control of the
FDR) when using the graphical approach of Bretz et al. (2009) and its extensions. We achieve this by
modifying and applying the methodology for k-FWER and FDP control given by van der Laan et al.
(2004) and Romano & Wolf (2010) to the graphical framework. The performance of the resulting
procedures are compared analytically and through simulations in the context of various case studies.
The rest of the paper is structured as follows. In Section 2, we introduce the basic notation and
the graphical approach to hypothesis testing. Section 3 shows how to modify the graphical approach
to control the k-FWER, while Section 4 gives a further modification of the graphical approach to
control the FDP as well as (asymptotic) control of the FDR. Section 5 shows how to use the proposed
procedures for a number of extensions to the graphical approach. We illustrate the proposed methods
using three case studies in Section 6, and conclude with a discussion in Section 7.
2 Graphical approach to hypothesis testing
Consider simultaneously testing multiple null hypotheses H1, . . . ,Hm which are related in some way
and so can be thought of as a family of hypothesis tests. Since we are jointly testing multiple hypothe-
ses, there is a resulting multiplicity problem that we wish to take account of in the testing procedure.
The standard approach for confirmatory clinical trials is to control the FWER (in the strong sense)
below some pre-specified level α, where α ∈ (0, 1). That is, P (V > 0) ≤ α under any configuration
of true and false null hypotheses, where V denotes the number of false rejections made. We con-
sider testing H1, . . . ,Hm using the corresponding p-values p1, . . . , pm. Let M = {1, . . . ,m} denote
the associated index set and assume that the p-values associated with the true null hypotheses satisfy
P (pi ≤ u) ≤ u for any u ∈ [0, 1].
We now describe the graphical approach to hypothesis testing introduced by Bretz et al. (2009),
which controls the FWER. In this approach, the hypotheses H1, . . . ,Hm are represented by vertices,
with associated weights denoting the significance levels. Any two vertices Hi and Hj are connected
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by a directed edge with weight gij , which indicates the fraction of the significance level αi which is
propagated from Hi to Hj if Hi is rejected. If gij = 0 then there is no propagation of the significance
levels, and the edge can be dropped for convenience from the graphical visualisation. These gij form
an m×m transition matrix G = (gij), which fully characterises the propagation of significance levels.
As an example, consider a trial in diabetes patients that compares two doses (a low dose and a
high dose) of an experimental drug against placebo, in terms of both a primary and secondary clinical
endpoint. Since the primary endpoint is more important than the secondary one, the trialist tests the
primary hypothesis first; only if this is rejected is the secondary hypothesis then tested. Assuming
that both doses are equally important, a possible testing strategy is shown in the graph in Figure 1,
as given in Maurer et al. (2011).
H1
α/2
H2
α/2
H3
0
H4
0
Primary
Secondary
Low dose High dose
1/2
1/2
1/2 1/2
1 1
Figure 1: Graph showing a possible testing strategy for a diabetes trial with a primary and secondary
endpoint that tests two doses of a drug against a placebo, as given in Maurer et al. (2011).
Bretz et al. (2011) proposed a graphical weighting strategy which allows the computation of the set
of weights for any intersection hypotheses HJ =
⋂
j∈JHj, J ⊆ M . The graphical weighting strategy
requires the specification of initial weights wi(M), i ∈ M , for the global null hypothesis HM and the
transition matrix G, with entries gij satisfying the regularity conditions
0 ≤ gij ≤ 1, gii = 0 and
m∑
j=1
gij ≤ 1 for all i, j ∈M (1)
Algorithm A1 in Appendix A reproduces the algorithm given in Bretz et al. (2011) for calculating the
weights wj(J), j ∈ J , which can then be used for testing the intersection hypothesis HJ .
Given these weights, a weighted multiple testing procedure can then be applied to each intersection
hypothesis HJ , such as a weighted Bonferroni test, or a weighted parametric test if the joint distribu-
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tion of the p-values is known (Bretz et al. 2011). Applying a weighted Bonferroni test is the simplest
option, and leads to the original Bonferroni-based graphical approach for FWER control based on a
shortcut procedure where the m hypotheses can be tested sequentially, and hence requires at most m
steps of the algorithm (Bretz et al. 2009) (see also Algorithm A2).
Adjusted p-values can also be calculated when using this graphical approach, which then allow
the hypothesis tests to be easily performed at any significance level α. More formally, the adjusted
p-value padjj for hypothesis Hj is the smallest significance level at which one can reject the hypothesis
using the given multiple test procedure (Bretz et al. 2009). Algorithm A3 in Appendix A reproduces
the algorithm given in Bretz et al. (2009) for calculating adjusted p-values.
The R package gMCP (Rohmeyer & Klinglmueller 2020) provides functions and a graphical user
interface to perform all of the calculations described above.
3 Graphical approaches for k-FWER control
Controlling the k-FWER at pre-specified level α implies that P (V > k) ≤ α, where V is the number
of false rejections. The generalised Bonferroni procedure controls the k-FWER (Lehmann & Romano
2005, Hommel & Hoffman 1988): Reject any Hi for which pi ≤ kα/m. Assuming known positive
weights wi that satisfy
∑m
i=1 wi = 1, Romano & Wolf (2010) introduced the weighted generalised
Bonferroni procedure: Reject any Hi for which pi ≤ wikα. If wi = 1/m for all i then this is equivalent
to the unweighted version.
In order to extend the graphical approach for controlling the k-FWER, it is tempting to simply
replace α by kα, in analogy to the modification made for the generalised Bonferroni procedures.
However, in general this does not control the k-FWER for k > 1. As a counterexample, consider
the Holm procedure with m hypotheses, which can be represented as a graph with initial weights
wi(M) = 1/m and gij = 1/(m − 1) for all i, j ∈ M , i 6= j. Using the graphical weighting strategy
(Algorithm A1), we have wi(I) = 1/|I| for all i ∈ I and I ⊆ M . Replacing α by kα in the graphical
approach (Algorithm A2) is hence equivalent to a stepdown procedure where the i-th smallest p-value
is compared with the significance level αi =
kα
m+1−i . However, since
kα
m+1−i >
kα
m+k−i for k > 1, the
result of Theorem 2.3 in Lehmann & Romano (2005) shows that this procedure does not control the
k-FWER. Hence we turn to alternative procedures for k-FWER control.
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3.1 Augmented graphical approach for k-FWER control
We first consider a simple method of controlling the k-FWER described in van der Laan et al. (2004,
Procedure 1), which can be applied to give a graphical approach for k-FWER control. The original
method starts with an initial procedure that controls the usual FWER, and then augments this by
additionally rejecting the hypotheses associated with the smallest k − 1 remaining (unrejected) p-
values. These k − 1 additionally rejected hypotheses can be freely chosen, and so we aim to respect
the hierarchical structure of the underlying multiple testing problem and to avoid rejecting hypotheses
with large p-values. This results in the following augmented graphical approach for k-FWER control.
Algorithm 1 – Augmented graphical approach for k-FWER control
(i) Apply the usual Bonferroni-based graphical procedure for FWER control given in Algorithm A2.
(ii) Let I denote the index set of any remaining (unrejected) hypotheses. If I is empty then stop;
otherwise continue with steps (ii)–(iv) of Algorithm A2 with α replaced by δ, until up to k − 1
additional (augmented) rejections are made.
Here δ ≥ 0 determines how many of the ‘free’ rejections we use, and can be set larger than α. In fact,
we can even set δ large enough to ensure that k − 1 additional hypotheses are rejected, regardless of
the observed p-values (see below). Of course, this comes at the potential cost of rejecting hypotheses
with p-values close to 1 that are likely to be null. Conversely, low values of δ mean that we are only
willing to reject a hypothesis if it has reasonably substantial evidence against it.
In step (ii) of Algorithm A2, there may be a choice as to which of the hypotheses j ∈ I to reject.
Since there can only be a maximum of k additional rejections in step (ii) of Algorithm 1, the order in
which hypotheses are rejected does matter here. One sensible choice is to set j = argmini∈I{pi/wi(I)},
which we use in the remainder of the paper.
The choice of δ can be data-dependent to ensure that (up to) k− 1 additional rejections are made.
More explicitly, we can increase δ so that one additional rejection is made, then if necessary increase
δ until another additional rejection is made, and so on. This allows an alternative formulation of
the augmented graphical approach based on adjusted p-values, which does not depend on an explicit
choice of δ.
Algorithm 2 – Adjusted augmented graphical approach for k-FWER control
(i) Calculate the m adjusted p-values padji corresponding to the usual Bonferroni-based graphical
procedure for FWER control, as detailed in Algorithm A3.
(ii) Reject all hypotheses Hi with p
adj
i ≤ α.
(iii) Let I denote the index set of any remaining (unrejected) hypotheses. If I is empty then stop;
otherwise order the remaining hypotheses in non-decreasing order: padj(1) ≤ · · · ≤ p
adj
(|I|)
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(iv) Additionally reject up to A = min(|I|, k − 1) hypotheses H(i) corresponding to p
adj
(1) , . . . , p
adj
(A)
If there are ties in the ordering in step (iii), they can be broken by choosing the hypothesis with the
smallest index, for example. Algorithm 1 will give the same rejections as Algorithm 2 for δ large
enough. In addition, the R package gMCP (Rohmeyer & Klinglmueller 2020) can straightforwardly be
used to implement Algorithm 1 in two stages corresponding to steps (i) and (ii). Hence, we focus on
Algorithm 1 in the rest of the paper.
Example 1 – Example of the augmented graphical approach for k-FWER control
Consider the graph of the diabetes trial given in Figure 2, where we control the k-FWER for k = 2
with α = 0.05. Suppose also that the p-values are given by p1 = 0.01, p2 = 0.03, p3 = 0.02, p4 = 0.024.
Initial graph End of step (i) (H1 rejected)
H1
α/2
H2
α/2
H3
0
H4
0
1/2
1/2
1/2 1/2
1 1
H2
3δ/4
H3
δ/4
H4
0
2/31/2
1/2
1
1/3
Final graph (H2 rejected)
H3
δ/2
H4
δ/2
1
1
Figure 2: The augmented graphical approach for k-FWER control applied to the diabetes trial.
In step (i) of Algorithm 1, the usual Bonferroni-based graphical procedure for FWER control would
only rejectH1. The updated graph (i.e. removing nodeH1 and propagating the local significance levels)
is then used in step (ii) of Algorithm 1, with α replaced by δ. Supposing that δ = 0.5, we would then
reject H2. At this point, we have made k − 1 additional rejections, and so we stop testing having
rejected H1 and H2. Figure 2 demonstrates each step of the augmented procedure graphically.
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3.2 Generalised graphical approach for k-FWER control
As an alternative approach, we focus on Algorithm A1, which gives weights wj(J), j ∈ J , for any
J ⊆M . As shown in Bretz et al. (2009), these weights satisfy the monotonicity condition
wj(J) ≤ wj(J
′) for all J ′ ⊆ J ⊆M and j ∈ J ′. (2)
Hence, we can apply the generic stepdown method for k-FWER control described in Romano & Wolf
(2010, Algorithm 4.1) with these weights to give the following generalised Bonferroni-based algorithm.
Essentially, we simply set the critical constants cˆn,K,i(1−α, k) in their algorithm equal to wi(K), where
K is used in step (iv) of Algorithm 3 below to index the subsets including k − 1 of the previously
rejected hypotheses. In what follows, we refer to this as the generalised graphical approach for k-
FWER control.
Algorithm 3 – Generalised graphical approach for k-FWER control
(i) Set I =M .
(ii) Reject any Hi, i ∈ I for which pi ≤ wi(I)kα
(iii) Let R = {i ∈ I : pi ≤ wi(I)kα}. If |R| < k or |R| = |I| then stop; otherwise update I → I \R.
(iv) Reject any Hi, i ∈ I for which
pi ≤ min
J⊆R,|J |=k−1
{wi(K) : K = I ∪ J}kα
If no such Hi exists then stop; otherwise let R
′ be the indices of these rejected hypotheses.
(v) Update the sets I and R as follows:
I → I \R′
R→ R ∪R′
(vi) If |I| ≥ 1, go to step (iv); otherwise stop.
In Algorithm 3, at each step R is simply the set of indices of all the hypotheses that have been rejected
previously, and I is the set of indices of the remaining hypothesesM \R. The algorithm is in a similar
spirit to the graphical weighting strategy (Bretz et al. 2011), in the sense that there is a separation
between the weighting strategy and the graphical test procedure which allows the generalisation to
k-FWER control.
In step (iii) of Algorithm 3, if |R| < k − 1 and |R| 6= |I| then we can freely reject additional
hypotheses so that a total of (up to) k−1 rejections are made, while still controlling the k-FWER, since
the algorithm will stop at this step. In order to respect the hierarchical structure of the underlying
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multiple testing procedure, and to avoid rejecting hypotheses with large p-values, we propose the
following sub-procedure in step (iii) if |R| < k − 1:
1. Set I → I \ R and follow steps (ii)–(iv) of the usual Bonferroni-based graphical procedure for
FWER control (Algorithm A2) with α replaced by δ, until up to k−1 additional rejections have
been made.
As before, δ ≥ 0 determines how many of the ‘free’ rejections we use, and hence can be set larger than
α or made data-dependent so that (up to) k − 1 additional rejections are made.
Looking at Algorithm 3 as a whole, if k = 1, then once a hypothesis is rejected, it no longer
plays a further role and step (iv) above reduces to rejecting any Hi, i ∈ I, for which pi ≤ wi(I)α.
Hence, Algorithm 3 is equivalent to Algorithm A2 (the usual Bonferroni-based graphical approach for
FWER control) in that both algorithms will lead to exactly the same rejections when k = 1, assuming
the same initial weights. When k > 1, however, the algorithm becomes more complex and involves
maximising over subsets including k − 1 of the previously rejected hypotheses in step (iv). As noted
by Romano & Wolf (2010), intuitively this is because when considering a set of unrejected hypothesis
in Algorithm 3, we may have already rejected (hopefully at most) k − 1 true null hypotheses. We do
not know which of the rejected hypotheses are true, and so we maximise over subsets including at
most k − 1 of those hypotheses previously rejected. In Appendix B.1 we discuss the computational
challenges of using Algorithm 3 for large values of m, and show how to streamline and operationalise
the algorithm. However, in general these modified procedures only give asymptotic control of the
k-FWER as the sample size of the trial increases.
In Appendix B.2 we give some examples of using the generalised graphical approach. We show
how it reduces to previous algorithms for k-FWER control as special cases, but also how it can have
undesirable properties when the testing procedure has a hierarchical structure. The main problem
(as demonstrated analytically in Example 4 of Appendix B.2) is that if a hypothesis Hj has fewer
than k donors, its initial significance level will never increase, except for up to k − 2 hypotheses via
the sub-procedure in step (iii). Here, the donors of a hypothesis Hj are the hypotheses that donate
(or propagate) their significance levels to Hj if they are rejected. Hence, the generalised graphical
approach cannot effectively propagate the significance levels through the graph. We will see further
examples of this in the case studies given in Section 6.
Example 2 – Example of the generalised graphical approach for k-FWER control
We again consider the graph of the diabetes trial given in Figure 1. We control the k-FWER for k = 2
with α = 0.05, with the p-values this time given by p1 = 0.01, p2 = 0.03, p3 = 0.02, p4 = 0.024.
Applying the generalised graphical approach for k-FWER control gives the following:
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1. Set I = {1, 2, 3, 4}.
2. We reject any Hi, i ∈ I, for which pi ≤ wi(I)kα. Here wi(I) are simply the initial weights and
so w1(I) = w2(I) = 0.5 and w3(I) = w4(I) = 0. Since p1 < α, p2 < α, H1 and H2 are rejected
at this step.
3. We reject Hi, i ∈ I = {3, 4}, if pi ≤ min{wi({1, 3, 4}), wi({2, 3, 4})}. However, w3({1, 3, 4}) =
w4({2, 3, 4}) = 0 and hence neither H3 nor H4 can be rejected.
3.3 Existing power comparisons
Romano & Wolf (2007) argue that the augmented procedure is suboptimal compared with their generic
stepdown method for k-FWER control, since it can only reject at most k−1 hypotheses more compared
to a usual FWER-controlling procedure, whereas Algorithm 3 can reject substantially more hypotheses.
In their simulation study (Romano & Wolf 2007, Section 6), they considered testing the means of a
multivariate normal distribution with common correlation ρ, where the number of hypothesesM = 50
or M = 400. They compared a number of different procedures for k-FWER control, but the relevant
power comparison for our context of graphical approaches is the one between the generalised Holm
procedure and the augmented Holm procedure. Their simulation results showed that when M = 400,
k = 10 and ρ ≤ 0.5, the generalised Holm procedure can make a substantially higher number of
rejections (up to twice as many) compared with the augmented Holm procedure. However, when
M = 50 and k = 3, the augmented Holm procedure almost always had a higher number of rejections
than the generalised Holm procedure.
These findings are corroborated by the simulation results of Dudoit et al. (2004). They also consid-
ered testing the means of a multivariate normal distribution, with the number of hypotheses M = 24
orM = 400. Through simulation, they compared the augmented and generalised Holm and Bonferroni
procedures, concluding that the augmented approach tends to be more powerful than the generalised
approach “for a broad range of models”(Dudoit et al. 2004, Section 6.2.1). The largest gains in power
were when the number of hypotheses was small and a large proportion of the null hypotheses were
true. However, for a large number of hypotheses (M = 400) and when α was relatively large, the
generalised approaches was more powerful than the augmented approaches. In many clinical trials, we
would be in the setting with a smaller number of hypotheses, and so the augmented approach would
be expected to be more powerful. In our case studies in Section 6, we consider power comparisons
beyond Bonferrroni or Holm based methods.
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4 Graphical approaches for FDP and (asymptotic) FDR control
In this section, we consider how to extend the graphical approach for FDP and (asymptotic) FDR
control. More formally, the FDP is defined as FDP = Vmax(R,1) , where R denotes the total number of
rejections. The FDR is then the expectation of the FDP. A multiple testing procedure controls the
tail probability of the FDP at level α if P (FDP > γ) ≤ α, where γ ∈ [0, 1) is a pre-specified bound.
This is also known as the tail probability for the proportion of false positives (Dudoit et al. 2004) or
the false discovery exceedance (Javanmard & Montanari 2018). Note that setting γ = 0 results in
control of the FWER at level α. In what follows, when we refer to FDP control, we mean controlling
this tail probability of the FDP, where we suppress the dependence on γ for notational convenience.
4.1 Augmented approach for FDP and FDR control
A simple method of controlling the FDP based on a FWER-controlling procedure is given by van der Laan et al.
(2004, Procedure 2). This can be applied to give an augmented graphical approach for FDP con-
trol, in a similar way to that for k-FWER control. A proof that FDP control holds can be found
in van der Laan et al. (2004, Theorem 2).
Algorithm 4 – Augmented graphical approach for FDP control
(i) Apply the usual Bonferroni-based graphical FWER procedure given in Algorithm A2. Let R
denote the index set of the rejected hypotheses.
(ii) Let I denote the index set of any remaining (unrejected) hypotheses. If I is empty, then stop.
(iii) Let D be the largest integer satisfying
D
D + |R|
≤ γ
If D = 0 then stop; otherwise continue with steps (ii)–(iv) of Algorithm A2 with α replaced by
δ, until up to D additional (augmented) rejections are made.
Here δ ≥ 0 is a constant controlling how many additional rejections are made. As before, δ may be
greater than α, and can be set very large so that all D additional hypotheses are rejected. The choice
of δ can also be data-dependent, giving an alternative algorithm based on adjusted p-values, which
does not depend on an explicit choice of δ.
Algorithm 5 – Adjusted augmented graphical approach for FDP control
(i) Calculate the m adjusted p-values padji corresponding to the usual Bonferroni-based graphical
procedure for FWER control, as detailed in Algorithm A3.
(ii) Reject all hypotheses Hi with p
adj
i ≤ α.
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(iii) Let I denote the index set of any remaining (unrejected) hypotheses. If I is empty then stop;
otherwise order the remaining hypotheses in non-decreasing order: padj(1) ≤ · · · ≤ p
adj
(|I|)
(iv) Additionally reject up to A = min(|I|,D) hypotheses H(i) corresponding to p
adj
(1) , . . . , p
adj
(A)
If there are ties in the ordering in step (iii), they can be broken by choosing the hypothesis with the
smallest index. Algorithm 4 will give the same rejections as Algorithm 5 for δ large enough. Also,
the R package gMCP (Rohmeyer & Klinglmueller 2020) can straightforwardly be used to implement
Algorithm 4 in two stages corresponding to steps (i) and (iii). Hence, we focus on Algorithm 4 in the
remainder of the paper.
Example 3 – Example of the augmented graphical approach for FDP control
We continue the example of the diabetes trial displayed in Figure 1, where this time we aim to
control the FDP with α = 0.05 and δ = 0.5. Suppose this time the p-values are given by p1 = 0.01,
p2 = 0.015, p3 = 0.02, p4 = 0.024. In step (i), the Bonferroni-based graphical procedure for FWER
control would reject H1 and H2. We then reject up to D additional hypotheses in step (iii), where
D is the largest integer satisfying D/(D + 2) ≤ γ. Hence if 0 ≤ γ < 1/3 we make D = 0 additional
rejections, if 1/3 ≤ γ < 1/2 we make D = 1 additional rejection (reject H3), and if γ ≥ 1/2 we make
D = 2 additional rejections (reject H3 and H4).
Although our focus in this paper is on controlling the tail probability of the FDP, we note in passing
that the augmented procedure for FDP control at level α automatically gives asymptotic control
of the FDR at level 2α. This follows directly from van der Laan et al. (2004, Theorem 3). Hence,
applying the augmented graphical approach for FDP control given in Algorithm 4 at pre-specified
level α asymptotically controls the FDR at level 2α. Lehmann & Romano (2005) showed that FDP
control at level α also implies FDR control at level α∗ = α(1 − γ) + γ. Hence, if α∗ < 2α, which
implies that γ < α/(1 − α), this bound can be used instead, while also yielding finite sample FDR
control.
4.2 Generalised graphical approach for asymptotic FDP control
As an alternative method to control the FDP, we can directly apply the generic method for FDP
control in Romano & Wolf (2010, Algorithm 8.1) to give the following graphical approach.
Algorithm 6 – Generalised graphical approach for asymptotic FDP control
(i) Let j = 1 and k1 = 1
(ii) Apply the kj-FWER procedure given in Algorithm 3, and let Rj denote the index set of the
hypotheses it rejects.
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(iii) If |Rj | < kj/γ−1, stop and reject all hypotheses rejected by the kj-FWER procedure. Otherwise,
let j = j + 1 and kj = kj−1 + 1, then return to step (ii).
This algorithm was only proven in Romano & Wolf (2010) to give asymptotic FDP control, but they
showed empirically that it had good finite control of the FDP. However, since Algorithm 6 is based
on the k-FWER generalised graphical approach, the same potential problems as described in Ap-
pendix B.2 will also apply. Finally, we again note in passing that the result of Lehmann & Romano
(2005) shows that this procedure gives (asymptotic) FDR control at level α∗ = α(1 − γ) + γ.
Example 4 – Example of the generalised graphical approach for FDP control
We continue the example of the diabetes trial displayed in Figure 1, where we aim to control the
FDP with α = 0.05 and δ = 0.5. Suppose the p-values are given by p1 = 0.01, p2 = 0.015, p3 = 0.02,
p4 = 0.024. In step (ii), applying the FWER procedure results in the rejection of H1 and H2. Hence
|R1| = 2 and we stop if γ < 1/3. If γ ≥ 1/3, then we apply the 2-FWER procedure, which again
rejects H1 and H2. Hence |R2| = 2 and we stop if γ < 2/3. If γ ≥ 2/3, then we apply the 3-FWER
procedure, which rejects H1 and H2. Since |R3| = 2 < 3/γ − 1 for all γ < 1 we would stop at this
step.
4.3 Existing power comparisons
Romano & Wolf (2007) argue that the augmented procedure for FDP control is suboptimal compared
with their generalised method for FDP control, given that both are based on the k-FWER controlling
procedures. In the simulation results for FDP controlling procedures given in Dudoit et al. (2004)
and Romano & Wolf (2007), the augmented and generalised approaches as given above (Algorithms 4
and 6) are not directly compared for Holm (or Bonferroni) based procedures. However, given their
simulation results for k-FWER control, we might also expect the augmented approach to have a higher
power than the generalised approach when the number of hypotheses are small or when the proportion
of true null hypotheses is high. We consider such power comparisons in our case studies in Section 6.
5 Extensions to the graphical approach
The original Bonferroni-based graphical approach of Bretz et al. (2009) has been extended in a number
of ways (Bretz et al. 2014). These extensions can be used in the augmented and generalised procedures
for k-FWER and FDP control.
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5.1 Entangled graphs
Firstly we consider the setting where it is desirable for the graphical procedures to have memory, in the
sense that the propagation of significance levels depends on their origin. To achieve this, we can define
individual graphs for each relationship and combine them afterwards. This is known as an entangled
graph, and the algorithm presented in Maurer & Bretz (2013a) gives an entangled Bonferroni-based
graphical approach.
Hence, we can straightforwardly modify the augmented graphical approaches for k-FWER and
FDR control for use with entangled graphs. To do so, simply replace Algorithm A2 with the algorithm
of Maurer & Bretz (2013a). For the adjusted augmented graphical approaches, replace Algorithm A3
with the algorithm of Maurer & Bretz (2014), which shows how to calculate adjusted p-values for the
entangled graph setting. Maurer & Bretz (2013a) also showed how to calculate the weights for any
intersection hypothesis HJ , J ⊆ M , and this weighting strategy satisfies the monotonicity condition
given in equation (2). Hence, we can directly apply this weighting strategy to the generalised graphical
approaches for k-FWER and FDP control. We give an example of the use of entangled graphs in the
case study described in Section 6.2.
5.2 Weighted parametric tests
All the procedures so far have been based on weighted Bonferroni tests, which can be conservative.
As an alternative, weighted parametric tests can be used if the joint distribution of the p-values pj,
j ∈ J , are known for the intersection hypothesis HJ . In this case, a weighted min-p test can be
defined (Westfall & Young 1993, Westfall et al. 1998). This test rejects HJ if there exists a j ∈ J such
that pj ≤ cJwj(J)α, where cJ is the largest constant satisfying
PHJ
⋃
j∈J
{pj ≤ cjwj(J)α}
 ≤ α.
If only some of the multivariate distributions of the p-values are known, then Bretz et al. (2011)
and Xi et al. (2017) showed how to derive conservative upper bounds on this rejection probability,
and hence determine a value for cI .
The motonocity condition in this setting is
cJwj(J) ≤ cJ ′wj(J
′) for all J ′ ⊆ J ⊆M and j ∈ J ′. (3)
which implies that rejection thresholds are always more liberal when fewer hypotheses are included in
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the set. In practice, this condition is often violated when using weighted parametric tests (Bretz et al.
2011). If this is the case, then it may be possible to modify the weighting scheme so that equation (3)
holds (Bretz et al. 2011, Xi et al. 2017). If the monotonicity condition does hold, then we can use the
weighted parametric tests directly for the augmented and generalised approaches for k-FWER and
FDP control, with the only change being that wi(I) is replaced by cIwi(I). For the adjusted augmented
graphical approach, adjusted p-values can be constructed for weighted parametric tests (Xi et al. 2017).
5.3 Group sequential designs
The graphical approach can also be extended to group sequential designs with one or more interim
analyses. Under mild monotonicity conditions,Maurer & Bretz (2013b) proposed a graphical testing
procedure for multiple hypotheses and multiple interim analyses. More formally, consider testing
H1, . . . ,Hm in a group sequential trial at time points t = 1, . . . , h. Each Hi has an associated error
spending function ai(κ, y) with information fraction y and significance level κ. The nominal significance
levels are denoted by α˜i,t(κ), which are the interim decision boundaries. We assume that these nominal
levels satisfy the monotonicity condition α˜i,t(κ
′) ≥ α˜i,t(κ) for all κ
′ > κ (i.e. the rejection boundaries
are always higher when the total error rate of the design is higher). These conditions hold for many
spending functions, including O’Brien-Fleming and Pocock boundaries (Maurer & Bretz 2013b). The
algorithm presented in Maurer & Bretz (2013b) gives a Bonferroni-based graphical test procedure for
group sequential designs.
The augmented graphical approaches for k-FWER and FDP control can hence be extended to
apply to group sequential designs: simply replace Algorithm A2 with the algorithm in Maurer & Bretz
(2013b). For the adjusted augmented graphical approach, replace Algorithm A3 with the algorithm
of Maurer & Bretz (2014), which shows how to calculate adjusted p-values for the group sequential
design setting.
6 Case Studies
In this section, we compare and contrast the use of the algorithms for k-FWER and FDP control
on three clinical case studies covering a broad range of clinical trial applications. In Section 6.1 we
revisit an exploratory pharmacodynamic clinical trial to investigate the effect of drug activity at the
GABA-A receptor in the brain. In Section 6.2 we revisit a proof-of-concept trial investigating three
doses of a new drug against a placebo on multiple biological endpoints related to acute heart failure.
Finally, in Section 6.3 we illustrate the proposed approaches for the comparison of three therapies in
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a confirmatory clinical trial for heart failure patients.
6.1 Pharmacodynamic study
Our first case study is motivated by the exploratory pharmacodynamic clinical study reported by Ferber et al.
(2011), which explored the effect of drug activity at the GABA-A receptor in the brain as measured
using a quantitative electroencephalogram (qEEG). Three doses of the drug (0.25mg, 0.5mg and 1mg)
were tested as well as a placebo. During the first 15 minutes after the drug was given to each patient,
qEEG measurements were taken and afterwards subdivided into 5 time slices of 3 minutes duration.
The analysis strategy used a mixed effect linear model to obtain 15 contrasts to formally test. Contrast
TiDj compared the change from baseline under dose j (j = 1, 2, 3) at time point i (i = 1, . . . , 5) to the
corresponding change under placebo. Figure 3 shows the graph representing the hierarchical testing
strategy used for these 15 hypotheses (with modified initial weights, see below), and Table 1 gives the
unadjusted p-values from the mixed effects linear model for the 15 hypotheses.
Time
Dose T1 T2 T3 T4 T5
D1 0.7808 0.0600 0.0137 0.0724 0.0162
D2 0.9433 0.0053 6.5× 10
−6 2.8× 10−6 9.1× 10−8
D3 0.9993 1.0× 10
−5 1.7× 10−11 4.2× 10−12 8.1× 10−13
Table 1: Table of p-values for the pharmacodynamic study of Ferber et al. (2011).
Figure 3 shows that the hypotheses T4D3 and T5D2 each only have a single donor hypothesis
(T5D3). Hence if they have initial weights of zero (as in the original graph (Ferber et al. 2011)), then
they cannot be rejected by the generalised graphical approach for k-FWER control with k = 2. This
then means that no hypotheses can be rejected except for T5D3. Therefore, we first set the initial
weights for T4D3, T5D2 and T5D3 to 1/3, with all other weights set equal to zero.
Table 2 shows the resulting rejections for the generalised and augmented graphical k-FWER and
FDP controlling procedures, with δ = 1. Looking first at the k-FWER procedures, for k = 1 the
generalised and augmented graphical procedures both reject the same 8 hypotheses, as would be
expected. For k = 2 and k = 3, the augmented procedure rejects 9 and 10 hypotheses respectively.
However, the generalised graphical procedure rejects fewer hypotheses when k = 2 and k = 3, with
only 3 rejections in both cases. For k = 3 this is because all hypotheses have fewer than 3 donors
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Figure 3: Graph representing the testing strategy for the pharmacodynamic study described
in Ferber et al. (2011), with modified initial weights. Here contrast TiDj compares the change from
baseline under dose j (j = 1, 2, 3) at time point i (i = 1, . . . , 5) to the corresponding change under
placebo.
and hence only those hypotheses with non-zero initial weights can be rejected. This is still the case
when k = 2, even though all hypotheses (except for T5D3) have 2 donors, showing that the generalised
graphical procedure cannot effectively propagate the significance levels through the graph.
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Procedure Rejected hypotheses
k-FWER
Generalised
k = 1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
k = 2 T4D3, T5D2, T5D3
k = 3 T4D3, T5D2, T5D3
Augmented
k = 1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
k = 2 T2D3, T3D2, T3D3, T4D1, T4D2, T4D3, T5D1, T5D2, T5D3
k = 3 T2D3, T3D1, T3D2, T3D3, T4D1, T4D2, T4D3, T5D1, T5D2, T5D3
FDP
Generalised
γ = 0.1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
γ = 0.2 T4D3, T5D2, T5D3
γ = 0.3 T4D3, T5D2, T5D3
Augmented
γ = 0.1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
γ = 0.2 T2D3, T3D1, T3D2, T3D3, T4D1, T4D2, T4D3, T5D1, T5D2, T5D3
γ = 0.3 T2D2, T2D3, T3D1, T3D2, T3D3, T4D1, T4D2, T4D3, T5D1, T5D2, T5D3
Table 2: Rejected hypotheses for the pharmacodynamic study of Ferber et al. (2011), with initial
weights of 1/3 for T4D3, T5D2 and T5D3.
There is a similar pattern for the FDP controlling procedures, which is expected given that they are
based on the k-FWER controlling procedures. For γ = 0.1 the generalised and augmented graphical
procedures give the same 8 rejections, which are also the same as the k-FWER controlling procedures
when k = 1. For γ = 0.2 and γ = 0.3, the augmented procedure rejects 10 and 11 hypotheses
respectively. However, again the generalised graphical procedure rejects fewer hypotheses for the
larger values of γ = 0.2 and γ = 0.3, with only 3 hypotheses rejected. These are the same rejections
as the generalised k-FWER controlling procedure for k > 1, because kj > 1 in Algorithm 6.
We also consider the setting where all 15 hypotheses have initial weight of 1/15. Table 3 shows
the resulting rejections for the generalised and augmented graphical k-FWER and FDP controlling
procedures, with δ = 1. With these new initial weights, the k-FWER controlling procedures both
reject the same 7 hypotheses when k = 1 and the same 8 hypotheses with k = 2. This shows how
the generalised graphical procedure can benefit with non-zero initial weights. However, for k = 3 the
augmented procedure rejects one more hypothesis (T5D1) than the generalised graphical procedure.
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This is because all hypotheses have fewer than 3 donors, and hence the weights for the generalised
graphical procedure cannot increase – i.e. there is no propagation of the significance levels.
Similarly, the FDP controlling procedures both reject the same 7 hypotheses when γ = 0.1 and
the same 8 hypotheses when γ = 0.2, which are also the same rejections as the k-FWER controlling
procedures when k = 1 and k = 2 respectively. However, for γ = 0.3 the augmented procedure rejects
two more hypotheses than the generalised graphical procedure, while the latter only gives the same
rejections as when γ = 0.2. This is because when γ = 0.3, kj > 2 in Algorithm 6 and there is no
propagation of the significance levels.
Procedure Rejected hypotheses
k-FWER
Generalised
k = 1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
k = 2 T2D2, T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
k = 3 T2D2, T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
Augmented
k = 1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
k = 2 T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
k = 3 T2D2, T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
FDP
Generalised
γ = 0.1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
γ = 0.2 T2D2, T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
γ = 0.3 T2D2, T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
Augmented
γ = 0.1 T2D3, T3D2, T3D3, T4D2, T4D3, T5D2, T5D3
γ = 0.2 T2D3, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
γ = 0.3 T2D2, T2D3, T3D1, T3D2, T3D3, T4D2, T4D3, T5D1, T5D2, T5D3
Table 3: Rejected hypotheses for the pharmacodynamic study of Ferber et al. (2011) with initial weights
of 1/15 for each hypothesis.
6.2 The Pre-RELAX-AHF trial
Our second case study is a proof-of-concept trial called the Preliminary study of RELAXin in Acute
Heart Failure (Pre-RELAX-AHF) (Teerlink et al. 2009). The trial compared 3 doses of relaxin against
a placebo on multiple biological endpoints related to acute heart failure. Given that this was a proof-
20
of-concept trial, less stringent error rates can be used when adjusting for multiplicity.
One criterion for recommending the treatment for further testing is to show an effect on the
majority of multiple endpoints. Following Davison et al. (2011), we consider a subset of 9 endpoints.
We focus on the 30µg/kg/day dose of relaxin treatment, which showed efficacy on 6 of these endpoints
when compared to placebo, using one-sided (uncorrected) p-values with α = 0.1. In what follows,
we call the 30µg/kg/day dose of relaxin treatment the experimental treatment, and the placebo the
control treatment.
Since the experimental treatment was declared efficacious in 6 out of 9 endpoints in the pre-
RELAX-AHF trial, we consider a trial design where it is required to reject at least 6 out of 9 hypotheses
to declare success. Calling these the primary hypotheses, we then add a hierarchical structure to this
trial by supposing that we also test secondary hypotheses if at least 6 out of the 9 primary hypotheses
were rejected. Hence we have a family of primary hypotheses F1 = (H1, . . . ,H9) corresponding
to testing the experimental treatment against the control across the 9 endpoints, and a family of
secondary hypotheses F2.
We can represent this 6-out-of-9 gatekeeping procedure using entangled graphs, which were de-
scribed in Section 5.1. More precisely, we can define gatekeeping graphs for all
(
9
6
)
= 84 possible subsets
of 6 primary hypotheses and then entangle them (Maurer & Bretz 2013a). We perform a Holm pro-
cedure HP l on 6 hypotheses for each of the 84 subsets of size 6, which we denote Jl, l = 1, . . . , 84.
The full significance level α is passed on to F2 if all 6 hypotheses in F1l = {Hi : i ∈ Jl} are rejected.
The testing procedure is given by the entangled graph E (c,HP l; l = 1, . . . , 84) where ci = 1/84 for
i = 1, . . . , 84.
This is equivalent to the following testing strategy: the usual Holm procedure is performed on the 9
hypotheses in F1 at level α until any six of these hypotheses are rejected. The remaining primary and
secondary hypotheses are then tested using the weights given in Table 4, which depend on the number
|I| of unrejected hypotheses in F1. For simplicity, in what follows we suppose that F2 consists of a
single hypothesis H10 (which could, for example, represent a composite safety endpoint). We can then
use the weights given in Table 4 in the k-FWER and FDP controlling graphical procedures.
In our simulation study, for the primary hypotheses F1 we follow Delorme et al. (2016) and take
the empirical means and standard errors of the endpoints as the true parameter values for the ex-
perimental (E) and control (C) treatments. The numerical values of the means µC , µE and standard
deviations σC , σE are given in Appendix C. We assume that the distributions of the observed means
of the endpoints for the experimental and control treatments follow a multivariate normal distribu-
tion: X¯G ∼ N(µG,ΣG) where G ∈ {C,E} and ΣG = diag(σG)Σ(ρ)diag(σG). Here diag(σG) is a
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|I| Weight for each hypothesis in F1 Weight for F2 = {H10}
> 3 1/|I| 0
3 83/252 1/84
2 11/24 1/12
1 2/3 1/3
0 – 1
Table 4: Table of weights for the entangled graph procedure used to analyse the trial based on Pre-
RELAX-AHF. Here |I| denotes the number of unrejected hypotheses in F1.
diagonal matrix with the i-th diagonal element equal to µGi , and Σ(ρ) is a correlation matrix with
ones on the diagonal and ρ on all off-diagonal terms. The test statistic for endpoint i is given by
Ti =
(
V̂ar(X¯Ei − X¯
C
i )
)−1/2 (
X¯Ei − X¯
C
i
)
, which is compared with a t-distribution. The estimator of
the variance of the difference between the means, as well as the appropriate degrees of freedom for the t-
distribution are given by Delorme et al. (2016) and implemented in their R package rPowerSampleSize
(de Micheaux et al. 2018). For the secondary hypothesis H10, for simplicity we assume that the test
statistic T10 follows a normal distribution with mean 3 and variance 1, and is independent of the test
statistics for F1.
Table 5 gives the marginal power to reject each hypothesis H1, . . . H10, calculated using 10
4 trial
replications, with α = 0.1 and δ = 1. The results show that in all scenarios, the augmented procedure
has an equal or higher power to reject each of the hypotheses H1, . . . ,H10. For the primary hypotheses
H1, . . . ,H5 and H8, this is especially noticeable for the k-FWER controlling procedures when k = 2
and k = 3. For hypothesis H9, the augmented procedures have a substantially higher power compared
with the generalised graphical procedure (except for when controlling the usual FWER). However,
H9 is actually a true null hypothesis (with µ
C
9 = µ
E
9 = 0.07) and so this implies a higher type I error
rate for H9 when using the augmented procedure. In fact the type I error rate for H9 is below or
equal to the nominal 10% in all scenarios for the generalised graphical procedures. Finally, for the
secondary hypothesis H10 (which has an initial weight of zero), we see that the power decreases as k
and γ increases for the k-FWER and FDP controlling generalised graphical procedures respectively
(in particular, the power is only 6% when γ = 0.3 for the latter procedure). Again this shows
that in contrast to the augmented procedures, the generalised graphical approaches do not effectively
propagate the significance levels when there is a hierarchical structure in the hypotheses.
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Procedure Marginal power
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10
k-FWER
k = 1
Generalised 95 89 72 78 85 100 100 62 6 64
Augmented 95 89 72 78 85 100 100 62 6 64
k = 2
Generalised 97 93 79 84 90 100 100 70 9 60
Augmented 99 97 90 92 95 100 100 87 65 84
k = 3
Generalised 98 95 81 86 92 100 100 73 10 42
Augmented 100 99 96 97 98 100 100 95 87 95
FDP
γ = 0.1
Generalised 95 89 72 78 85 100 100 62 8 61
Augmented 95 89 72 78 85 100 100 63 38 65
γ = 0.2
Generalised 95 92 78 83 89 100 100 70 9 50
Augmented 96 93 82 86 90 100 100 77 52 73
γ = 0.3
Generalised 96 93 80 85 90 100 100 72 10 6
Augmented 97 94 86 88 92 100 100 83 58 83
Table 5: Simulated marginal powers to reject hypotheses H1, . . . ,H10, with α = 0.1 and the distri-
bution of the test statistics for F1 = (H1, . . . ,H9) based on the Pre-RELAX-AHF trial reported by
Teerlink et al. (2009). Results are based on 104 independent trial replications.
6.3 ATMOSPHERE study
Our final case study is motivated by the confirmatory ATMOSPHERE study (Krum et al. 2011) in
patients with heart failure. As described in Maurer & Bretz (2014), the trial compared three ther-
apies: aliskiren monotherapy (A), enalapril monotherapy (E), and aliskiren/enalapril combination
therapy (C). This resulted in three single primary hypotheses (H1,H2,H3) and two families of sec-
ondary hypotheses (H4,H5):
H1: non-superiority of C versus E
H2: inferiority of A versus E
H3: non-superiority of A versus E
H4 = {H41,H42}: two secondary endpoints for comparing C versus E
H5 = {H51,H52}: two secondary endpoints for comparing A versus E
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The graph on the left-hand side in Figure 4 shows the graphical test procedure used in Maurer & Bretz
(2014) to analyse the trial. Note that if all individual null hypotheses inH4 orH5 are rejected, the local
significance level is propagated to the remaining hypotheses. For simplicity, we apply a Holm proce-
dure within each of the two secondary families H4 and H5. Following Maurer & Bretz (2014), suppose
we observe the (hypothetical) unadjusted p-values p1 = 0.1, p2 = 0.007, p3 = 0.05, p41 = 0.0015,
p42 = 0.04, p51 = 0.0031 and p52 = 0.001.
Initial graph Augmented graphical approaches
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Figure 4: The graph on the left-hand side was used for the ATMOSPHERE study, as presented
in Maurer & Bretz (2014). The graph on the right-hand side is the updated graph at the start of
step (ii) in the augmented graphical approach for either k-FWER or FDP control, after H2,H51 and
H52 have been rejected.
Consider first controlling the k-FWER with k = 2 and α = 0.025. For the augmented graphical
approach (given in Algorithm 1), in step (i) the Bonferroni-based graphical procedure for FWER
control would reject H2, H51 and H52. The updated graph used at the start of step (ii) is shown in
the right-hand side of Figure 4, where α has been replaced by δ. Supposing that δ = 0.5, step (ii)
of the algorithm rejects H3. Since we have made one additional (augmented) rejection, at this point
we stop. As for the generalised graphical approach for k-FWER control (given in Algorithm 3), in
step (ii) we would only reject H2. Since the number of rejections |R| = k − 1, we stop at this point.
Now consider controlling the FDP with γ = 0.3. For the augmented graphical approach (given
in Algorithm 4), in step (i) we reject H2, H51 and H52 like before. In step (ii), we can reject one
additional hypothesis, and hence we reject H3 and then stop. Finally, for the generalised graphical
approach (given in Algorithm 6), we first apply the usual Bonferroni-based graphical procedure for
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FWER control, which rejects H2, H51 and H52. Since |R1| > 1/γ − 1, we then apply the 2-FWER
procedure which (as above) only rejects H2. Since |R2| < 2/γ − 1, we stop and only reject H2.
7 Discussion
In this paper, we have showed how to generalise the graphical approach of hypothesis testing (Bretz et al.
2009) so that the k-FWER or the FDP can be controlled. By applying the methodology of Romano & Wolf
(2010) and van der Laan et al. (2004), we have proposed generalised and augmented graphical ap-
proaches for both k-FWER and FDP control (as well as an augmented procedure for asymptotic FDR
control). Crucially, these approaches respect the hierarchical structure of the underlying multiple test-
ing procedure given by the graphical weighting strategy. We have also applied the proposed graphical
approaches to three real-life case studies covering a broad range of clinical trial applications.
Our recommendation is that the augmented graphical approaches should be used instead of the
generalised graphical approaches. Firstly, the generalised graphical approach for k-FWER control has
the undesirable property that if a hypothesisHj has fewer than k donors, its initial significance level will
not increase. Hence, the generalised graphical approach cannot effectively propagate the significance
levels through the graph. The case studies in Section 6 show how this can have a detrimental effect on
the power of the generalised graphical approach – the power to reject hypotheses with fewer than k
donors can actually decrease as k increases. Since the generalised graphical approach for FDP control
is based on the generalised graphical approach for k-FWER control, a similar problem occurs.
In contrast, the augmented graphical approach is able to propagate significance levels to all hy-
potheses that have fewer than k donors. As a consequence, the power of the augmented graphical
approach for k-FWER control and FDP control increases as k and γ increase (respectively). Impor-
tantly, in all of the case studies in Section 6, the augmented graphical approach had a higher power (or
rejected at least as many hypotheses) compared with the generalised graphical approach. These re-
sults are backed up by existing power comparisons for the generalised and augmented Holm procedure
(Romano & Wolf 2007, Dudoit et al. 2004) when testing a relatively small number of hypotheses.
The research for this paper was motivated by clinical trial applications ranging from early to
late drug development, as illustrated by the case studies in Section 6. Outside of the context of
clinical trials and the graphical weighting strategy of Bretz et al. (2009), another area of application
is testing hypotheses in a directed acyclic graph (DAG) for use in gene set analysis, as proposed
by Meijer & Goeman (2015). The authors presented a top-down method that strongly controls the
FWER, and by considering the genes and gene sets as nodes in a DAG, the method allows testing for
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simultaneous testing of both significant gene sets and individual genes. The testing procedure starts
with an initial weight for each of the leaf nodes (i.e. nodes without any descendants), and an iterative
weighting procedure is used to update the weights for all the other nodes in the graph. These weights
also satisfy the monotonicity condition given in equation (2), and so suitably modified versions of the
augmented and generalised graphical approaches could be used in this setting.
As future work, it would be desirable to derive adjusted p-values for all of the proposed proce-
dures, especially for the augmented graphical approaches. This would involve extending the results
of van der Laan et al. (2004), who showed how to calculate adjusted p-values for their augmented
approach. Finally, the initial motivation for this paper came from considering the generalised closure
principle (Guo & Rao 2010), which was applied to derive stepup procedures for k-FWER control.
The usual graphical approach for FWER corresponds to defining a shortcut closed testing proce-
dure (Bretz et al. 2009). It would be interesting to formalise a similar link between the generalised
graphical approach for k-FWER control and the generalised closure principle.
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A Graphical weighting strategy and weighted Bonferroni test for
FWER control
For a given index set J ⊆M , let Jc =M \J denote the set of indices not contained in J
Algorithm A1 – Graphical weighting strategy (Bretz et al. 2011, Algorithm 1)
(i) Set I =M
(ii) Select j ∈ Jc and remove Hj
(iii) Update the graph:
I → I \{j}, Jc → Jc \{j}
wl(I)→
{
wl(I) + wj(I)gjl l ∈ I
0 otherwise
glh →

glh + gljgjh
1− gljgjl
l, h ∈ I, l 6= h, gljgjl < 1
0 otherwise
(iv) If |Jc| ≥ 1, go to step (ii); otherwise set wl(J) = wl(I), l ∈ J and stop.
The weights wj(J), j ∈ J , generated by this procedure are unique (Bretz et al. 2009), and in particular
do not depend on which order the hypotheses Hj, j ∈ J
c are removed in Algorithm A1.
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Algorithm A2 – Bonferroni-based graphical test for FWER control (Bretz et al. 2011, Al-
gorithm 2)
(i) Set I =M
(ii) Select a j ∈ I such that pj ≤ wj(I)α and reject Hj; otherwise stop.
(iii) Update the graph:
I → I \ {j}
wl(I)→
{
wl(I) + wj(I)gjl l ∈ I
0 otherwise
glh →

glh + gljgjh
1− gljgjl
l, h ∈ I, l 6= h, gljgjl < 1
0 otherwise
(iv) If |I| ≥ 1, go to step (ii); otherwise stop.
The final decisions of the algorithm do not depend on which order the hypotheses are rejected. For
example, step (ii) above could be replaced by choosing j = argmini∈I{pi/wi(I)}.
Algorithm A3 – Adjusted p-values (Bretz et al. 2009, Algorithm 2)
(i) Set I =M and pmax = 0
(ii) Let j = argmini∈I pi/wi(I)
(iii) Calculate padjj = max{pj/wj(I), pmax} and set pmax = p
adj
j .
(iv) Update the graph:
I → I \ {j}
wl(I)→
{
wl(I) + wj(I)gjl l ∈ I
0 otherwise
glh →

glh + gljgjh
1− gljgjl
l, h ∈ I, l 6= h, gljgjl < 1
0 otherwise
(v) If |I| ≥ 1, go to step (ii); otherwise stop.
(vi) Reject all hypotheses Hj with p
adj
j ≤ α
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B Further results on the generalised graphical approach
B.1 Streamlined and operative versions of the generalised graphical approach
Apart from special cases, applying the generalised graphical approach given in Algorithm 3 can be
computationally intensive for larger values of m, particularly since the weights wi(K) need to be
calculated using Algorithm A1. For large values of m, we can directly apply the streamlined version of
the general stepdown method for controlling the k-FWER in Romano & Wolf (2010, Algorithm 4.2)
to give a streamlined version of Algorithm 3. The way this version works is to avoid minimising over
all subsets of size k− 1 of previously rejected hypothesis, and only consider the least significant k− 1
of the previous rejections. Note that this only gives asymptotic control of the k-FWER (as the sample
size of the trial increases).
Algorithm B1 – Streamlined graphical approach for k-FWER control
Given an index set R of rejected hypohteses, let p1:R ≤ p2:R ≤ · · · ≤ p|R|:R denote the ordered p-values,
with corresponding hypotheses H1:R,H2:R, . . . ,H|R|:R. Denote by {r1, . . . , r|R|} the permutation of
{1, . . . , |R|} that gives this ordering, so that p1:R = pr1 , . . . , p|R|:R = pr|R| . The streamlined algorithm
is the same as Algorithm 3, except that at step (iv) we now reject anyHi, i ∈ I for which pi ≤ wi(K)kα,
where K = I ∪ {r|R|−k+2, . . . , r|R|}.
The streamlined version only gives asymptotic control of the k-FWER, but involves no minimisa-
tion over any subsets. In order to get closer to the original, exact algorithm while still retaining com-
putational feasibility, as a compromise we can use the operative method proposed in Romano & Wolf
(2010, Remark 3.3). Consider that to compute the critical value in step (iv) of Algorithm 3, one has
to evaluate
( |R|
k−1
)
weights in order to choose the minimum. The operative method maximises over
subsets not necessarily of the entire index set R of previously rejected hypotheses, but only for some
number B least significant hypotheses so far. More precisely, we have the following algorithm:
Algorithm B2 – Operative graphical approach for k-FWER control Pick a user-specified
number Nmax and let B be the largest integer for which
( B
k−1
)
≤ Nmax. The operative method is the
same as Algorithm 3, except that step (iv) rejects any Hi, i ∈ I for which
pi ≤ min
J⊆{rmax{1,|R|−B+1},...,r|R|},|J |=k−1
{wi(K) : K = I ∪ J}kα
When B ≥ |R| we maximise over all subsets of R of size k− 1 like in the original algorithm, while the
streamlined algorithm is a special case of the operative method where Nmax = 1 and hence B = k− 1.
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B.2 Examples of the generalised graphical approach
Example 5 – Generalised Weighted Bonferroni
Suppose each vertex on the graph is unconnected, i.e. gij = 0 for all i, j ∈ M . Algorithm A1 implies
that wj(J) = wj(M), j ∈ J for all J ⊆M . Hence the inequality in step (iv) of Algorithm 3 is simply
pi ≤ wi(M)kα and so there is no further testing after step (ii), unless δ > 0 and |R| < k − 1. Thus
when δ = 0, Algorithm 3 is exactly the same as the generalised weighted Bonferroni procedure in
Section 2 with wi = wi(M).
Example 6 – Generalised Holm
To represent the Holm procedure with m hypotheses, we set the initial weights wi(M) = 1/m and
gij = 1/(m− 1) for all i, j ∈M , i 6= j. Hence using Algorithm A1, we have wi(I) = 1/|I| for all i ∈ I
and I ⊆M , and the inequality in step (iv) of Algorithm 3 is simply
pi ≤
kα
|I|+ k − 1
=
kα
m+ k − |R| − 1
For δ = 0, this gives identical rejections to the generalised Holm procedure as given in Lehmann & Romano
(2005).
Example 7 – Hierarchical testing: fixed sequence test and fallback procedure
In a fixed sequence test, the hypotheses are tested in a pre-specified order. This allows each hypothesis
to be tested at the full level α while controlling the FWER, with the proviso that if any hypothesis
is not rejected then no further testing is allowed. Suppose the pre-specified ordering for testing m
hypotheses is H1 → H2 → · · · → Hm. Hence we have gij = 1 for i = 1, . . . ,m − 1 if j = i + 1 and
gij = 0 otherwise.
If we follow the usual fixed sequence test and set w1(M) = 1 and wi(M) = 0, i = 1, . . . ,m−1, then
only H1 can be rejected in step (ii) of the Algorithm 3 and hence the algorithm will never proceed to
step (iv) since |R| < k. Hence, a more natural generalisation of the fixed sequence test is to set the
initial weights as wi(M) = 1/k for i = 1, . . . , k and wi(M) = 0 otherwise. This means that the first k
hypotheses will be tested at full level α. However, assume that the first k hypotheses are all rejected
(otherwise we proceed to the sub-procedure of step (iii) and can only reject up to the first k − 1
hypotheses). Since wi({1, . . . , k − 1, k + 1, . . . , i, . . . ,m}) = 0 for i = k + 1, . . . ,m, step (iv) of the
algorithm implies that no further hypotheses can then be rejected. For k > 1, this generalisation
of the fixed sequence test has the undesirable property that only the first k hypotheses can ever be
tested, even when using the sub-procedure of step (iii) with δ > 0.
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A similar issue occurs when generalising the fallback procedure (Wiens 2003), which is a modifi-
cation of the fixed sequence procedure where the initial weights wi(M) > 0 for all i ∈ M . Applying
Algorithm 3, suppose (without loss of generality, by relabelling the hypothesis labels) that the hy-
potheses H1, . . . ,Hk are all rejected at step (ii). However, since wi(I
⋃
{1, . . . , k − 1}}) = wi(M) for
all i ∈ I and I ⊆ {k + 1, . . . ,m}, step (iv) implies that the hypotheses Hi, i = k + 1, . . . ,m, are
also tested at significance level wi(M)kα. So for k > 1, this generalisation of the fallback procedure
has the undesirable property that rejecting hypotheses does not lead to an increase in the significance
levels of the remaining hypotheses, except via the sub-procedure of step (iii) when δ > 0 (but even
then, the propagation is limited to at most k − 1 hypotheses).
Example 8 – Hypotheses with fewer than k donors
We can generalise the previous example to any graph where any hypothesis has fewer than k donors,
where the donors of a hypothesis Hj are the hypotheses that donate (or propagate) their significance
levels to Hj if they are rejected. More formally, we denote the donors of hypothesis Hj by do(Hj) =
{Hi : gij > 0}. Note that two hypotheses Hi and Hj can be donors to each other.
If a hypothesis Hj in a graph has fewer than k donors, then applying the generalised graphical
approach has the undesirable property that the initial significance level for Hj can never increase, even
if all its donors are rejected (except for up to k − 2 hypotheses via the sub-procedure in step (iii)).
To see this, suppose δ = 0 and all donors of Hj have been rejected (and |R| ≥ k, or else there is no
propagation). In step (iv) of Algorithm 3, since |do(Hj)| ≤ k − 1 then
min
J⊆R,|J |=k−1
{wi(K) : K = I ∪ J}kα ≤ wi (I ∪ do(Hj)) kα = wi(M)kα
Hence Hj is tested using the initial weights in step (iv). In particular, this means that if a hypothesis
with fewer than k donors has an initial weight of zero, then it can never be rejected (except possibly
via the sub-procedure in step (iii)). This can be an undesirable property to have in a testing procedure
which has a hierarchical structure, as we will see further in the case studies in Section 6.
As an example, consider the graph for the diabetes trial shown in Figure 1, and suppose we wish
to control the k-FWER for k = 2. Since the secondary hypotheses H3 and H4 only have one donor
each (hypotheses H1 and H2, respectively) and start with a weight of zero, they will never be rejected
even if more than one of the primary hypotheses H1 and H2 are rejected.
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C Parameter values for the Pre-RELAX-AHF trial
In our simulation study, for the primary hypotheses H1, . . . ,H9 we take the empirical means and
standard errors of the endpoints as the true parameter values for the experimental (E) and control (C)
treatments. The numerical values of the means µC , µE and standard deviations σC , σE are given
in Delorme et al. (2016) and reproduced below:
µC = (0.23, 1679, 0.79,−12, 44.2, 0.828, 0.857, 0.13, 0.07)
µE = (0.4, 2567, 0.88,−10.2, 47.9, 0.974, 1, 0.21, 0.07)
σC = (
√
0.23(1 − 0.23), 2556,
√
0.79(1 − 0.79), 7.3, 14.2,
√
0.828(1 − 0.828),
√
0.857(1 − 0.857),√
0.13(1 − 0.13),
√
0.07(1 − 0.07))
= (0.421, 2556, 0.407, 7.3, 14.2, 0.377, 0.350, 0.336, 0.255)
σE = (
√
0.4(1 − 0.4), 2898,
√
0.88(1 − 0.88), 6.1, 10.1,
√
0.974(1 − 0.974), 10−12,
√
0.21(1 − 0.21),√
0.07(1 − 0.07))
= (0.490, 2898, 0.325, 6.1, 10.1, 0.159, 10−12 , 0.407, 0.255)
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